Introduction
In December 2019, cluster of patients with pneumonia were reported in Wuhan, Hubei Province, China. 1, 2 Shortly, a new coronavirus, temporally named 2019-nCov, was identified to be the cause of the disease, which is the seventh member of the family betacoronavirus. 1 More than 2,700 infection cases and 80 deaths were reported as of 27
January 2020 from China. In addition, infection cases have been reported from Thailand, Australia, Malaysia, Singapore, France, Japan, South Korea, the United States, Vietnam, Canada and Nepal, indicating that the disease is a potential threat to the global health. 3 Sadly, the number is still growing rapidly and no drug has been approved to be effective.
Therefore, it is urgent to discover and develop drugs to cure the disease.
Based on its function, the main protease (M pro ) or chymotrypsin-like protease (3CL pro ) 4 is suggested to be a potential drug target to combat 2019-nCov, which is with improving scoring and minimization. The hydrogens were added to 2019-nCov M pro model by pdb2pqr (--ff=amber --ffout=amber --chain --with-ph=7). 13 Then the model was converted to pdbqt format by prepare_receptor4.py script in MGLToos version 1.5.6. 10 The ligand in 2GTB was used to define the grid and the buffer space was set to 6.0 Å (autobox_add). The random seed was explicitly set to 0 (seed). The exhaustiveness of the global search was set to 32 (exhaustiveness) and at most 1 binding mode was generated for each drug (num_modes). MolShaCS, which utilized Gaussianbased description of molecular shape and charge distribution, was used to calculate the 3D similarities between approved drugs and available M pro inhibitors. 14 
Molecular dynamics simulation. Each simulation system was immersed in a cubic
box of TIP3P water that was extended by 9 Å from the solute, with a rational number of counter ions of Na + or Cl -to neutralize the system. General Amber force field (GAFF) 15 and Amber ff03 force field 16 were used to parameterize the ligand and protein, respectively. 10,000 steps of minimization with constraints (10 kcal/mol/Å 2 ) on heavy atoms of complex, including 5,000 steps of steepest descent minimization and 5,000 steps of conjugate gradient minimization, was used to optimize each system. Then each system was heated to 300 K within 0.2 ns followed by 0.1 ns equilibration in NPT ensemble. Finally, 5 ns MD simulation on each system at 300 K was performed. The minimization, heating and equilibrium are performed with sander program in Amber16.
The 5 ns production run was performed with pmemd.cuda.
Binding free energy calculation.
Based on the 5 ns MD simulation trajectory, bind free energy (ΔG) was calculated with MM/GBSA 17, 18 and SIE 19 approaches. In the MM/GBSA, the ΔG was calculated according to equation (1),
where ΔEele and ΔEVDW refer to electrostatic and van der Waals energy terms, respectively. ΔGgb and ΔGnp refer to polar and non-polar solvation free energies, respectively. Conformational entropy (TΔS) was calculated by nmode module in Amber16. The dielectric constants for solvent and solute were set to 80.0 and 1.0, respectively, and OBC solvation model (igb = 5 and PBradii = 5) 20 was used in this study. Other parameters are set to default values.
In the SIE, the ΔG was calculated based on equation (2),
where EC and EVDW refer to the sum of intermolecular Coulomb and van der Waals interaction energies, respectively. ΔG After visualizing the docked complexes carefully, we selected 15 drugs (Table 2) for further analysis. There are some differences between the conformations of the protein in the 3D similarity reference and 2GTB model. Therefore, we modelled 10 new homology models using the proteins in 3D similarity reference as templates and we redocked the 15 drugs to the 10 new homology models. 6 drugs (nelfinavir, pitavastatin, perampanel, praziquantel, zopiclone, and eszopiclone) show good docking scores and binding modes (Table 3) . Because eszopiclone and zopiclone was used to treat insomnia in a low dosage which may not be suitable to treat pneumonia, we carried out further binding free energy calculation for the rest 4 drugs. (Table 4) , which highlight nelfinavir as the most active one. In pitavastatin-2GTB, perampanel-5NH0, and praziquantel-3V3M, the van der Waals interaction (E vdw ) makes a more significant contribution than the electrostatic interaction (E ele ) ( Table 4 ), indicating that van der Waals interaction is the main driving force for the 3 drugs binding. However, the E ele interaction of nelfinavir-2GX4 is very strong, suggesting that the electrostatic interaction also play an important role in the binding of nelfinavir. Furthermore, in results of the SIE approach, the rank of the calculated binding free energies for the 4 docking complexes is consistent with that of the MM/GBSA approach ( Table 5 ) that the nelfinavir has the strongest binding free energy (-9.42±0.04 kcal/mol), indicating the reliability of the current binding free energy analysis. The statistical error was estimated based on 0.5-5 ns MD simulation trajectory. 500 snapshots evenly extracted from the 0.5-5 ns MD trajectory of complex were used for MM/GBSA calculations and 50 snapshots for the entropy term calculations. 
Results and discussion

Conclusions
2019-nCov caused more than 80 deaths in China as of 27 January 2020 and is a potential threat to the global health. However, there is no approved drug to treat the disease.
2019-nCov M pro is a potential drug target to combat the virus, which shares 96% sequence similarity with the corresponding one in SARS. We built 11 homology models 
